PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

A Glaviano, ASC Foo, HY Lam, KCH Yap, W Jacot… - Molecular cancer, 2023 - Springer
Abstract The PI3K/AKT/mTOR (PAM) signaling pathway is a highly conserved signal
transduction network in eukaryotic cells that promotes cell survival, cell growth, and cell …

AKT in cancer: new molecular insights and advances in drug development

PS Mundi, J Sachdev, C McCourt… - British journal of clinical …, 2016 - Wiley Online Library
The phosphatidylinositol‐3 kinase (PI3K)–AKT pathway is one of the most commonly
dysregulated pathways in all of cancer, with somatic mutations, copy number alterations …

Causes and consequences of increased glucose metabolism of cancers

RJ Gillies, I Robey, RA Gatenby - Journal of Nuclear Medicine, 2008 - Soc Nuclear Med
In this review we examine the mechanisms (causes) underlying the increased glucose
consumption observed in tumors within a teleological context (consequences). In other …

A review about the development of fucoidan in antitumor activity: Progress and challenges

L Wu, J Sun, X Su, Q Yu, Q Yu, P Zhang - Carbohydrate polymers, 2016 - Elsevier
Fucoidan is composed of l-fucose, sulfate groups and one or more small proportions of d-
xylose, d-mannose, d-galactose, l-rhamnose, arabinose, glucose, d-glucuronic acid and …

PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortality

E López‐Knowles, SA O'Toole… - … journal of cancer, 2010 - Wiley Online Library
Breast cancer is a common malignancy with current biological therapies tailored to steroid
hormone (ER, PR) and HER2 receptor status. Understanding the biological basis of …

Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers

CG Fedele, LM Ooms, M Ho… - Proceedings of the …, 2010 - National Acad Sciences
Inositol polyphosphate 4-phosphatase-II (INPP4B) is a regulator of the phosphoinositide 3-
kinase (PI3K) signaling pathway and is implicated as a tumor suppressor in epithelial …

PI3K‐independent AKT activation in cancers: A treasure trove for novel therapeutics

K Mahajan, NP Mahajan - Journal of cellular physiology, 2012 - Wiley Online Library
AKT/PKB serine threonine kinase, a critical signaling molecule promoting cell growth and
survival pathways, is frequently dysregulated in many cancers. Although …

Plant Derived Bioactive Compounds, Their Anti-Cancer Effects and In Silico Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An Updated …

V Shrihastini, P Muthuramalingam, S Adarshan… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer is one of the leading causes of death among women
worldwide. Breast cancer may be provoked due to several physical, chemical and …

Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma

L Qi, J Bart, LP Tan, I Platteel, T Sluis, S Huitema… - BMC cancer, 2009 - Springer
Background Flat epithelial atypia (FEA) of the breast is characterised by a few layers of
mildly atypical luminal epithelial cells. Genetic changes found in ductal carcinoma in situ …

Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival

S Uddin, AR Hussain, AK Siraj, PS Manogaran… - Blood, 2006 - ashpublications.org
Abstract Phosphatidylinositol 3′-kinase (PI3K) is a key player in cell-growth signaling in a
number of lymphoid malignancies, but its role in diffuse large B-cell lymphoma (DLBCL) has …